ArticleClinical pharmacology and therapeutics2020

Postmarketing Safety-Related Regulatory Actions for New Therapeutic Biologics Approved in the United States 2002-2014: Similarities and Differences With New Molecular Entities.

Ilynn Bulatao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.